Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

600196

Classement en actions #2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Prix de l'action
$3.40
Capitalisation boursière
$9.07B
Changement (1 jour)
-1.61%
Changement (1 an)
-16.08%
Pays
CN
Échange Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)

Catégorie

Healthcare
Historique des dividendes pour Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (symbole boursier : 600196) a versé un total de 26 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $5.75
Rendement du dividende (TTM) : 0.0172
Versements de dividendes pour Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) de 2001 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
2026 (TTM) $0.39 21.88%
2025 $0.32 18.52%
2024 $0.27 -35.71%
2023 $0.42 -25.00%
2022 $0.56 30.23%
2021 $0.43 10.26%
2020 $0.39 21.88%
2019 $0.32 -15.79%
2018 $0.38 8.57%
2017 $0.35 9.37%
2016 $0.32 14.29%
2015 $0.28 3.70%
2014 $0.27 28.57%
2013 $0.21 110.00%
2012 $0.1 0.00%
2011 $0.1 49.93%
2010 $0.0667 0.00%
2009 $0.0667 0.00%
2008 $0.0667 0.00%
2007 $0.0667 -61.75%
2006 $0.1744 239.96%
2005 $0.0513 -25.00%
2004 $0.0684 149.64%
2003 $0.0274 7.03%
2002 $0.0256 8.02%
2001 $0.0237 0.00%
Liste de tous les paiements de dividendes
Année Dividende Changez
2026 (TTM) $0.39 21.88%
2025 $0.32 18.52%
2024 $0.27 -35.71%
2023 $0.42 -25.00%
2022 $0.56 30.23%
2021 $0.43 10.26%
2020 $0.39 21.88%
2019 $0.32 -15.79%
2018 $0.38 8.57%
2017 $0.35 9.37%
2016 $0.32 14.29%
2015 $0.28 3.70%
2014 $0.27 28.57%
2013 $0.21 110.00%
2012 $0.1 0.00%
2011 $0.1 0.00%
2010 $0.1 0.00%
2009 $0.1 0.00%
2008 $0.1 -23.08%
2007 $0.13 -61.76%
2006 $0.34 240.00%
2005 $0.1 -62.50%
2004 $0.2667 149.95%
2003 $0.1067 -17.92%
2002 $0.13 8.33%
2001 $0.12 0.00%
Dividendes versés par des entreprises similaires ou concurrentes